Bioccelerator Shifts Focus from Hardware to Software, Licenses GenCore 6.0 to USPTO | GenomeWeb

In 2003, Compugen co-founder Simchon Faigler purchased the rights to the company's Bioccelerator line of FPGA-based bioinformatics systems, creating a new firm called Biocceleration dedicated to selling and servicing the accelerated informatics system.

Two and a half years later, Biocceleration is now shifting its focus from the flagship hardware platform that has been on the market for more than a decade toward a software product that Faigler claims can offer comparable speedup to the FPGA boxes, but at a much lower cost.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.